Healing & RecoveryResearch OnlyD

Wolverine Blend

Wolverine Stack · BPC-157 + TB-500

Wolverine is a community name for a pre-blended recovery vial that combines BPC-157 and TB-500 (thymosin β4 fragment) into one tracked compound. PeptIQ lists it as an educational blend entry so supplier-labeled dual vials can be logged as a single injection while component research still maps to BPC-157 and TB-500. Not an FDA-approved fixed combination — verify the vial label and treat component evidence separately.

Observational report only — modeled community data. Not medical advice. Does not recommend doses, protocols, or treatments.
Studies cited
4
Research grade
D
Experience
76

Overall check-ins

Activity
82

Trackers & reports

Overview

About Wolverine Blend

Wolverine is a community name for a pre-blended recovery vial that combines BPC-157 and TB-500 (thymosin β4 fragment) into one tracked compound. PeptIQ lists it as an educational blend entry so supplier-labeled dual vials can be logged as a single injection while component research still maps to BPC-157 and TB-500. Not an FDA-approved fixed combination — verify the vial label and treat component evidence separately.

Category
Healing & Recovery
Regulatory status
Research Only
Also known as
Wolverine Stack · BPC-157 + TB-500
Self-reports
965

Community

What 965 users report

965 community reports

Overall experience

From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Favorable 59% · Mixed 28% · Unfavorable overall 13%

Most reported benefits

Benefits users selected when logging a favorable or mixed check-in.

Energy
-24
Mood
7
Focus
-57
Sleep quality
3
Lean mass
-57

Most logged side effects

Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Dizziness
-108
Fatigue
-93
Nausea
-92
Water retention
-1
Appetite loss
-58

Self-reported dose per injection

Median bucket: 0.2–0.4 mg · Most common: 0.2–0.4 mg

Reports span 0.025–2 mg

0.025–0.05 mg
3
0.05–0.1 mg
14
0.1–0.2 mg
23
0.2–0.4 mg
31
0.4–0.6 mg
25
0.6–1 mg
14
1–2 mg
9

Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.

Common discussion topics

timing49stacking22side effects25wolverine blend23

How repeat users are trending

Among repeat reporters, 54% said they felt similar to their last entry, 33% more positive, and 19% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 19 days · Based on 212 repeat reporters

Community charts use modeled aggregates when live Supabase snapshots are unavailable.

Research

Cited research (2)

PubMed

Stable gastric pentadecapeptide BPC 157: Novel therapy in gastrointestinal tract

Sikiric et al., 2018

Source
Wiki study page →

Tools

Explore more

Help

Frequently asked

What do PeptIQ users report about Wolverine Blend?

This page summarizes 965 anonymized self-reports from PeptIQ users who track Wolverine Blend, including commonly reported effects and co-tracked peptides. These are observational patterns, not clinical outcomes.

How do side effects relate to overall experience for Wolverine Blend?

PeptIQ separates overall check-in ratings (favorable, mixed, or unfavorable) from logged side effects like nausea or fatigue. Users often report benefits and side effects in the same check-in — a high experience score does not mean zero side effects were noted.

What research is cited for Wolverine Blend?

2 sources are linked on this page, including PubMed articles, clinical trial registries, and FDA labels where applicable. Citations describe published research — not recommendations.

Is Wolverine Blend safe to use?

This wiki does not assess safety or recommend use. Wolverine Blend is listed as Research Only. Consult a licensed clinician for personal medical decisions.

What are the purported benefits and uses of Wolverine Blend?

Research, primarily in animal models, suggests Wolverine Blend may have a wide range of therapeutic potentials due to its ability to promote angiogenesis (formation of new blood vessels), stimulate collagen synthesis, and modulate inflammatory responses.

Source

What is the legal status of Wolverine Blend?

Wolverine Blend is not approved by the FDA for any human use. There is no legal basis for selling it as a drug, food, or dietary supplement in the United States. The FDA has classified Wolverine Blend as a Category 2 bulk drug substance, which explicitly prohibits licensed compounding pharmacies from using it in compounded medications.

Source

What are the known or theoretical side effects and risks of Wolverine Blend?

The safety and effectiveness of Wolverine Blend have not been thoroughly evaluated in humans through rigorous clinical trials. This lack of human data means that safe dosages, short-term side effects, and long-term health consequences are largely unknown.

Source

What is the current state of research on Wolverine Blend?

While there are over 200 published studies on Wolverine Blend, the vast majority are animal or in vitro (cell) studies. These preclinical studies consistently show positive results across various tissue types. However, there is a significant lack of comprehensive human clinical trial data.

Source